Short answer
Omada Health, Inc. (OMDA) filed an 8-K current report with the SEC on August 6, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure/Election of Directors or Officers). Q2 2026 results announced for the three months ended June 30, 2026.
Omada Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results announced for the three months ended June 30, 2026
- Investor-relevant financial figures and management commentary are contained in Exhibit 99.1
- Results provide the latest operating update for Omada Health following August 6, 2026 disclosure
Item 5.02 · Departure/Election of Directors or Officers
- CEO transition effective January 1, 2027: President Wei-Li Shao succeeds Sean Duffy
- Duffy becomes Executive Chairman, preserving founder-level leadership and strategic continuity
- Shao appointed Class I director through the 2029 Annual Meeting
- Jeryl Hilleman becomes Lead Independent Director, strengthening board oversight
- Compensation changes for the transition remain unapproved、】【
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $87.8M, up 43% year over year, with total members up 45%, signaling strong demand and enrollment momentum
- Gross margin reached 73% from 66%, while adjusted EBITDA rose to $10.8M from a $0.2M loss, marking meaningful operating leverage
- GAAP net income reached $5.3M versus a $5.3M loss, though six-month free cash flow remained negative at $11.0M
- Raised 2026 outlook: revenue $334M to $340M and adjusted EBITDA $21M to $27M, up from prior ranges of $322M to $330M and $14M to $20M
- CEO transition effective January 1, 2027: Wei-Li Shao succeeds Sean Duffy, who becomes Executive Chair, creating a planned leadership handoff during rapid expansion
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Omada Health, Inc. 8-K filings
Get the next OMDA 8-K as it lands
Follow OMDA for push alerts, or ask the research agent what this filing means.